KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Shares Outstanding (Diluted Average) (2016 - 2025)

Charles River Laboratories International has reported Shares Outstanding (Diluted Average) over the past 10 years, most recently at $49.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 4.0% year-over-year to $49.6 million; the TTM value through Dec 2025 reached $49.6 million, down 4.0%, while the annual FY2025 figure was $49.6 million, 4.0% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $49.6 million at Charles River Laboratories International, roughly flat from $49.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $51.8 million in Q2 2024 and troughed at $49.4 million in Q3 2025.
  • A 5-year average of $51.2 million and a median of $51.4 million in 2021 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 2.22% in 2021 and later fell 4.42% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $51.4 million in 2021, then fell by 0.24% to $51.3 million in 2022, then increased by 0.29% to $51.5 million in 2023, then rose by 0.34% to $51.6 million in 2024, then fell by 4.0% to $49.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CRL at $49.6 million in Q4 2025, $49.4 million in Q3 2025, and $50.1 million in Q2 2025.